Literature DB >> 21036901

Synergistic Ca2+ responses by G{alpha}i- and G{alpha}q-coupled G-protein-coupled receptors require a single PLC{beta} isoform that is sensitive to both G{beta}{gamma} and G{alpha}q.

Robert A Rebres1, Tamara I A Roach, Iain D C Fraser, Finly Philip, Christina Moon, Keng-Mean Lin, Jamie Liu, Leah Santat, Lucas Cheadle, Elliott M Ross, Melvin I Simon, William E Seaman.   

Abstract

Cross-talk between Gα(i)- and Gα(q)-linked G-protein-coupled receptors yields synergistic Ca(2+) responses in a variety of cell types. Prior studies have shown that synergistic Ca(2+) responses from macrophage G-protein-coupled receptors are primarily dependent on phospholipase Cβ3 (PLCβ3), with a possible contribution of PLCβ2, whereas signaling through PLCβ4 interferes with synergy. We here show that synergy can be induced by the combination of Gβγ and Gα(q) activation of a single PLCβ isoform. Synergy was absent in macrophages lacking both PLCβ2 and PLCβ3, but it was fully reconstituted following transduction with PLCβ3 alone. Mechanisms of PLCβ-mediated synergy were further explored in NIH-3T3 cells, which express little if any PLCβ2. RNAi-mediated knockdown of endogenous PLCβs demonstrated that synergy in these cells was dependent on PLCβ3, but PLCβ1 and PLCβ4 did not contribute, and overexpression of either isoform inhibited Ca(2+) synergy. When synergy was blocked by RNAi of endogenous PLCβ3, it could be reconstituted by expression of either human PLCβ3 or mouse PLCβ2. In contrast, it could not be reconstituted by human PLCβ3 with a mutation of the Y box, which disrupted activation by Gβγ, and it was only partially restored by human PLCβ3 with a mutation of the C terminus, which partly disrupted activation by Gα(q). Thus, both Gβγ and Gα(q) contribute to activation of PLCβ3 in cells for Ca(2+) synergy. We conclude that Ca(2+) synergy between Gα(i)-coupled and Gα(q)-coupled receptors requires the direct action of both Gβγ and Gα(q) on PLCβ and is mediated primarily by PLCβ3, although PLCβ2 is also competent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036901      PMCID: PMC3020779          DOI: 10.1074/jbc.M110.198200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Functional organization of PLC signaling microdomains in neurons.

Authors:  Patrick Delmas; Marcel Crest; David A Brown
Journal:  Trends Neurosci       Date:  2004-01       Impact factor: 13.837

Review 2.  Calcium signalling: dynamics, homeostasis and remodelling.

Authors:  Michael J Berridge; Martin D Bootman; H Llewelyn Roderick
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

Review 3.  The roles of PDZ-containing proteins in PLC-beta-mediated signaling.

Authors:  P G Suh; J I Hwang; S H Ryu; M Donowitz; J H Kim
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

4.  Identification of critical regions on phospholipase C-beta 1 required for activation by G-proteins.

Authors:  D Wu; H Jiang; A Katz; M I Simon
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

5.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

Review 6.  Regulation of phosphoinositide-specific phospholipase C.

Authors:  S G Rhee
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 7.  Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+.

Authors:  Tim D Werry; Graeme F Wilkinson; Gary B Willars
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

8.  Stimulation of adenosine receptor enhances alpha 1-adrenergic receptor-mediated activation of phospholipase C and Ca2+ mobilization in a pertussis toxin-sensitive manner in FRTL-5 thyroid cells.

Authors:  F Okajima; K Sato; K Sho; Y Kondo
Journal:  FEBS Lett       Date:  1989-05-08       Impact factor: 4.124

9.  Cross talk between P2Y2 nucleotide receptors and CXC chemokine receptor 2 resulting in enhanced Ca2+ signaling involves enhancement of phospholipase C activity and is enabled by incremental Ca2+ release in human embryonic kidney cells.

Authors:  Tim D Werry; Graeme F Wilkinson; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

10.  Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits.

Authors:  M Camps; A Carozzi; P Schnabel; A Scheer; P J Parker; P Gierschik
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

View more
  25 in total

Review 1.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

Review 2.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

3.  Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter.

Authors:  Joshua M Baughman; Fabiana Perocchi; Hany S Girgis; Molly Plovanich; Casey A Belcher-Timme; Yasemin Sancak; X Robert Bao; Laura Strittmatter; Olga Goldberger; Roman L Bogorad; Victor Koteliansky; Vamsi K Mootha
Journal:  Nature       Date:  2011-06-19       Impact factor: 49.962

4.  Molecular mechanisms of phospholipase C β3 autoinhibition.

Authors:  Angeline M Lyon; Jessica A Begley; Taylor D Manett; John J G Tesmer
Journal:  Structure       Date:  2014-12-02       Impact factor: 5.006

5.  Mechanism of activation and inactivation of Gq/phospholipase C-β signaling nodes.

Authors:  T Kendall Harden; Gary L Waldo; Stephanie N Hicks; John Sondek
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 6.  Analgesic synergy between opioid and α2 -adrenoceptors.

Authors:  A-J Chabot-Doré; D J Schuster; L S Stone; G L Wilcox
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 7.  Targeting G protein-coupled receptor signalling by blocking G proteins.

Authors:  Adrian P Campbell; Alan V Smrcka
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

8.  Defect in phosphoinositide signalling through a homozygous variant in PLCB3 causes a new form of spondylometaphyseal dysplasia with corneal dystrophy.

Authors:  Salma Ben-Salem; Sarah M Robbins; Nara Lm Sobreira; Angeline Lyon; Aisha M Al-Shamsi; Barira K Islam; Nadia A Akawi; Anne John; Pramathan Thachillath; Sania Al Hamed; David Valle; Bassam R Ali; Lihadh Al-Gazali
Journal:  J Med Genet       Date:  2017-11-09       Impact factor: 6.318

9.  D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.

Authors:  Lani S Chun; R Benjamin Free; Trevor B Doyle; Xi-Ping Huang; Michele L Rankin; David R Sibley
Journal:  Mol Pharmacol       Date:  2013-05-16       Impact factor: 4.436

Review 10.  The structure of dynamic GPCR signaling networks.

Authors:  Patrick R O'Neill; Lopamudra Giri; W K Ajith Karunarathne; Anilkumar K Patel; K V Venkatesh; N Gautam
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2014 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.